导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.38% | 562/1050 |
| 近一周 | -1.67% | 284/1104 |
| 近一月 | -9.27% | 1007/1102 |
| 近一季 | 12.75% | 65/1092 |
| 近半年 | 4.07% | 336/1070 |
| 近一年 | -16.20% | 833/1018 |
| 近两年 | 21.83% | 756/926 |
| 近三年 | -0.30% | 680/834 |
| 成立以来 | 54.19% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.69% 699/1070 |
2.23% 656/1101 |
- - |
- - |
| 2025 | 18.12% 696/1065 |
7.19% 273/1014 |
10.67% 88/1038 |
14.66% 746/1050 |
-13.16% 956/1065 |
| 2024 | -16.49% 879/1011 |
-7.35% 666/960 |
-8.17% 794/983 |
9.07% 704/991 |
-10.01% 897/1011 |
| 2023 | -14.08% 484/952 |
-2.48% 732/880 |
-7.26% 652/895 |
-3.46% 228/915 |
-1.59% 201/952 |
| 2022 | -27.26% 563/867 |
-17.12% 366/773 |
-2.77% 737/806 |
-16.88% 678/845 |
8.59% 105/867 |
| 2021 | -6.44% 438/740 |
-1.58% 207/580 |
29.14% 58/659 |
-12.22% 566/704 |
-16.14% 692/740 |
| 2020 | 77.93% 101/554 |
7.94% 49/419 |
49.03% 8/466 |
2.70% 393/517 |
7.69% 398/554 |
| 2019 | 79.53% 11/410 |
38.62% 78/1149 |
1.02% 236/1231 |
21.51% 14/390 |
5.51% 330/410 |
| 2018 | -14.41% 24/349 |
- - |
- - |
- - |
-17.26% 959/1080 |
| 2017 | -3.45% 183/285 |
- - |
- - |
- - |
- - |
| 2016 | -14.38% 91/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 农银医疗保健股票 VS. 东吴新产业精选股票A(580008) |